Dyne Therapeutics Statistics Share Statistics Dyne Therapeutics has 142.26M
shares outstanding. The number of shares has increased by 13.21%
in one year.
Shares Outstanding 142.26M Shares Change (YoY) 13.21% Shares Change (QoQ) 0.48% Owned by Institutions (%) 99.99% Shares Floating 109.63M Failed to Deliver (FTD) Shares 5 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 17.14M, so 12.05% of the outstanding
shares have been sold short.
Short Interest 17.14M Short % of Shares Out 12.05% Short % of Float 13.45% Short Ratio (days to cover) 4.84
Valuation Ratios The PE ratio is -6.99 and the forward
PE ratio is -4.27.
Dyne Therapeutics's PEG ratio is
0.48.
PE Ratio -6.99 Forward PE -4.27 PS Ratio 0 Forward PS 2023.3 PB Ratio 3.52 P/FCF Ratio -7.53 PEG Ratio 0.48
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Dyne Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 15.6,
with a Debt / Equity ratio of 0.04.
Current Ratio 15.6 Quick Ratio 15.6 Debt / Equity 0.04 Debt / EBITDA -0.08 Debt / FCF -0.08 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.65M Employee Count 192 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -61.39% in the
last 52 weeks. The beta is 1.1, so Dyne Therapeutics's
price volatility has been higher than the market average.
Beta 1.1 52-Week Price Change -61.39% 50-Day Moving Average 11.03 200-Day Moving Average 14.15 Relative Strength Index (RSI) 57.92 Average Volume (20 Days) 3,050,283
Income Statement
Revenue n/a Gross Profit -2.24M Operating Income -343.89M Net Income -317.42M EBITDA -315.18M EBIT -317.42M Earnings Per Share (EPS) -3.37
Full Income Statement Balance Sheet The company has 435.45M in cash and 23.99M in
debt, giving a net cash position of 411.46M.
Cash & Cash Equivalents 435.45M Total Debt 23.99M Net Cash 411.46M Retained Earnings -949.93M Total Assets 728.99M Working Capital 656.48M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -292.37M
and capital expenditures -2.38M, giving a free cash flow of -294.75M.
Operating Cash Flow -292.37M Capital Expenditures -2.38M Free Cash Flow -294.75M FCF Per Share -3.13
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
